Veru Inc (VERU)
1.335
-0.02
(-1.11%)
USD |
NASDAQ |
May 10, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Veru Cash and Short Term Investments (Quarterly): 40.58M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 40.58M |
| September 30, 2023 | 9.626M |
| June 30, 2023 | 16.21M |
| March 31, 2023 | 23.50M |
| December 31, 2022 | 46.93M |
| September 30, 2022 | 80.19M |
| June 30, 2022 | 100.55M |
| March 31, 2022 | 112.02M |
| December 31, 2021 | 116.10M |
| September 30, 2021 | 122.36M |
| June 30, 2021 | 123.16M |
| March 31, 2021 | 136.68M |
| December 31, 2020 | 30.92M |
| September 30, 2020 | 13.59M |
| June 30, 2020 | 15.39M |
| March 31, 2020 | 2.558M |
| December 31, 2019 | 4.175M |
| September 30, 2019 | 6.295M |
| June 30, 2019 | 8.039M |
| March 31, 2019 | 5.896M |
| December 31, 2018 | 8.979M |
| September 30, 2018 | 3.760M |
| June 30, 2018 | 5.577M |
| March 31, 2018 | 8.972M |
| December 31, 2017 | 3.572M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.278M |
| June 30, 2017 | 2.671M |
| March 31, 2017 | 1.242M |
| December 31, 2016 | 3.485M |
| September 30, 2016 | 2.385M |
| June 30, 2016 | 3.211M |
| March 31, 2016 | 2.791M |
| December 31, 2015 | 3.672M |
| September 30, 2015 | 4.106M |
| June 30, 2015 | 2.625M |
| March 31, 2015 | 2.934M |
| December 31, 2014 | 4.569M |
| September 30, 2014 | 5.796M |
| June 30, 2014 | 4.142M |
| March 31, 2014 | 5.941M |
| December 31, 2013 | 7.991M |
| September 30, 2013 | 8.922M |
| June 30, 2013 | 11.88M |
| March 31, 2013 | 6.147M |
| December 31, 2012 | 4.275M |
| September 30, 2012 | 5.296M |
| June 30, 2012 | 8.287M |
| March 31, 2012 | 6.272M |
| December 31, 2011 | 4.661M |
| September 30, 2011 | 4.313M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.558M
Minimum
Mar 2020
136.68M
Maximum
Mar 2021
53.10M
Average
30.92M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 331.05M |
| Regeneron Pharmaceuticals Inc | 10.52B |
| Bio-Path Holdings Inc | 1.052M |
| Aileron Therapeutics Inc | 17.31M |
| Scholar Rock Holding Corp | 238.43M |